Mirago 50mg Tablet is a powerful medication used to treat overactive bladder (OAB) symptoms such as frequent or urgent urination. The active ingredient, Mirabegron Extended 50mg, works by relaxing the bladder muscles and increasing the bladder's capacity to hold urine, thereby reducing the symptoms of OAB. This tablet is designed for oral administration and should be taken as directed by your healthcare provider. Mirago 50mg Tablet is conveniently available for purchase at our online medical store, and we guarantee high-quality, genuine products for your peace of mind. Say goodbye to the inconvenience and discomfort of OAB with Mirago 50mg Tablet.

Mirago 50mg Tablet (Mirabegron Extended 50mg)

Name: Mirago 50mg Tablet (Mirabegron Extended 50mg)
Brand: Ivermectinkart
Price: 55 USD
Availability: InStock

$55.00

Pack Size

Quantity

Overactive bladder (OAB) symptoms, such as: Mirago 50mg Tablet is generally indicated for the management of OAB symptoms, including:

Frequent urination: Mirago 50mg Tablet reduces frequent urination by loosening the muscles that contract the bladder and expanding the bladder’s capacity for holding urine.

Urgency: It relieves and improves bladder control by helping to regulate the sudden, strong need to urinate.

Unintentional urine leaking is known as urinary incontinence, and Mirago 50mg Tablet can help to lessen these occurrences.

It is significant to remember that Mirago 50mg Tablet is designed to treat the symptoms of OAB rather than the underlying cause.
Dosage: 50 mg taken orally once daily is the suggested beginning dose for Mirago 50mg Tablets. Depending on how you react to the treatment, your doctor may change the dosage.

Administration: 50 mg of Mirago Tablets can be taken with or without food, and they should be taken with a glass of water. Take the tablet whole; do not chew or crush it.

Treatment time: Your healthcare professional will decide how long the course of action will last, and this time frame may change based on each patient’s response and the intensity of their symptoms. It’s crucial to stick to the recommended course of therapy and not stop taking the medication without first talking to your doctor.

Missed dose: If you forget to take a dose, do so right away. If your next dose is approaching, skip the missed one and carry on with your regular dosing regimen. To make up for a missing dose, do not double the dose.
Drug Interactions: Before taking Mirago 50 mg Tablet, let your doctor know about all the prescription, over-the-counter, and herbal supplements you are presently taking. Strong CYP3A inhibitors, for example, may interact with Mirago 50 mg Tablet and change its efficacy or raise the possibility of side effects. To ensure the safe and effective use of the medication, it is crucial to discuss any potential drug interactions with your doctor.

Contraindications: Mirago 50 mg Tablet should not be taken by some people. If any of the following apply to you:

There are no known allergies or sensitivities to Mirabegron or any other component of the pill.

severely impaired liver.

Dialysis is necessary due to end-stage renal disease or severe kidney damage.
Common adverse effects of Mirago 50mg Tablet include nausea, abdominal pain, dry mouth, headache, dizziness, and constipation. It is advised to see your doctor if any of these side effects persist or become bothersome even though they are often minor and temporary.

Serious side effects: Although they are uncommon, some people may experience serious negative effects from taking Mirago 50mg Tablet. In the event that you encounter any of the following, get medical help right away:

Allergic symptoms, including hives, itchiness, swelling, very dizzy, or breathing difficulties.

severe discomfort or chest agony.

irregular or fast heartbeat.

extreme lightheadedness or fainting.

an uncomfortable or protracted erection (priapism).

These are not the only adverse effects that Mirago 50mg Tablet could have. Contact your doctor for additional testing if you experience any other strange symptoms while taking this medicine.